These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35340605)

  • 1. Characteristic structural difference between inactive and active states of orexin 2 receptor determined using molecular dynamics simulations.
    Yokoi S; Mitsutake A
    Biophys Rev; 2022 Feb; 14(1):221-231. PubMed ID: 35340605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Dynamics Simulations for the Determination of the Characteristic Structural Differences between Inactive and Active States of Wild Type and Mutants of the Orexin2 Receptor.
    Yokoi S; Mitsutake A
    J Phys Chem B; 2021 May; 125(17):4286-4298. PubMed ID: 33885321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and Computational Insights into Dynamics and Intermediate States of Orexin 2 Receptor Signaling.
    Yokoi S; Suno R; Mitsutake A
    J Phys Chem B; 2024 Jun; 128(25):6082-6096. PubMed ID: 38722794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic behavior of the active and inactive states of the adenosine A(2A) receptor.
    Lee S; Bhattacharya S; Grisshammer R; Tate C; Vaidehi N
    J Phys Chem B; 2014 Mar; 118(12):3355-65. PubMed ID: 24579769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineating the activation mechanism and conformational landscape of a class B G protein-coupled receptor glucagon receptor.
    Wang Y; Li M; Liang W; Shi X; Fan J; Kong R; Liu Y; Zhang J; Chen T; Lu S
    Comput Struct Biotechnol J; 2022; 20():628-639. PubMed ID: 35140883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of corticotropin-releasing factor 1 receptor: insights from molecular dynamics simulations.
    Singh R; Ahalawat N; Murarka RK
    J Phys Chem B; 2015 Feb; 119(7):2806-17. PubMed ID: 25607803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A
    Ciancetta A; Rubio P; Lieberman DI; Jacobson KA
    J Comput Aided Mol Des; 2019 Nov; 33(11):983-996. PubMed ID: 31758354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revealing the Mechanism of Agonist-Mediated Cannabinoid Receptor 1 (CB1) Activation and Phospholipid-Mediated Allosteric Modulation.
    Díaz Ó; Dalton JAR; Giraldo J
    J Med Chem; 2019 Jun; 62(11):5638-5654. PubMed ID: 31095906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and dynamics of G-protein coupled receptors.
    Vaidehi N; Bhattacharya S; Larsen AB
    Adv Exp Med Biol; 2014; 796():37-54. PubMed ID: 24158800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying multiple active conformations in the G protein-coupled receptor activation landscape using computational methods.
    Dong SS; Goddard WA; Abrol R
    Methods Cell Biol; 2017; 142():173-186. PubMed ID: 28964335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of a constitutive active mutant of adenosine A
    Cui M; Zhou Q; Xu Y; Weng Y; Yao D; Zhao S; Song G
    IUCrJ; 2022 May; 9(Pt 3):333-341. PubMed ID: 35546802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand based conformational space studies of the μ-opioid receptor.
    Sena DM; Cong X; Giorgetti A
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129838. PubMed ID: 33373630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of human Orexin-1 and -2 G-protein-coupled receptors with novel and published antagonists by modeling, molecular dynamics simulations, and site-directed mutagenesis.
    Heifetz A; Morris GB; Biggin PC; Barker O; Fryatt T; Bentley J; Hallett D; Manikowski D; Pal S; Reifegerste R; Slack M; Law R
    Biochemistry; 2012 Apr; 51(15):3178-97. PubMed ID: 22448975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putative active states of a prototypic g-protein-coupled receptor from biased molecular dynamics.
    Provasi D; Filizola M
    Biophys J; 2010 May; 98(10):2347-55. PubMed ID: 20483344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Conformational State Transitions of Class B GPCRs Using Molecular Dynamics.
    Liao C; May V; Li J
    Methods Mol Biol; 2019; 1947():3-19. PubMed ID: 30969408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of activation of a G protein-coupled receptor, the human cholecystokinin-2 receptor.
    Marco E; Foucaud M; Langer I; Escrieut C; Tikhonova IG; Fourmy D
    J Biol Chem; 2007 Sep; 282(39):28779-28790. PubMed ID: 17599907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conserved Mechanism of Conformational Stability and Dynamics in G-Protein-Coupled Receptors.
    Bhattacharya S; Salomon-Ferrer R; Lee S; Vaidehi N
    J Chem Theory Comput; 2016 Nov; 12(11):5575-5584. PubMed ID: 27709935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example.
    Zeng L; Guan M; Jin H; Liu Z; Zhang L
    Chem Biol Drug Des; 2015 Dec; 86(6):1438-50. PubMed ID: 26072970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent advances in the structural biology of the class C G protein-coupled receptors: The metabotropic Glutamate receptor 5].
    Berto L; Dumazer A; Malhaire F; Cannone G; Kutti Ragunath V; Goudet C; Lebon G
    Biol Aujourdhui; 2021; 215(3-4):85-94. PubMed ID: 35275053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.